Vaccines against asexual stage malaria parasites.
Kumar
Sanjai
S
Malaria Program, Naval Medical Research Center, Silver Spring, Md., USA. kumarS@cber.fda.gov
Epstein
Judith E
JE
Richie
Thomas L
TL
D000328:Adult; D000818:Animals; D000953:Antigens, Protozoan / Q000276:immunology / Q000502:physiology; D001029:Aotus trivirgatus; D002448:Cell Adhesion; D015815:Cell Adhesion Molecules / Q000378:metabolism; D002648:Child; D017321:Clinical Trials, Phase I as Topic; D004912:Erythrocytes / Q000469:parasitology; D005544:Forecasting; D018503:Genome, Protozoan; D006790:Host-Parasite Interactions / Q000276:immunology; D006801:Humans; D007113:Immunity, Innate; D007117:Immunization, Secondary; D008288:Malaria / Q000276:immunology / Q000517:prevention & control; D017780:Malaria Vaccines / Q000276:immunology; D051379:Mice; D008970:Molecular Weight; D009032:Mosquito Control; D010865:Pilot Projects; D010961:Plasmodium / Q000254:growth & development / Q000276:immunology*; D015800:Protozoan Proteins / Q000276:immunology / Q000502:physiology; D019444:Vaccines, DNA / Q000276:immunology; D022223:Vaccines, Subunit / Q000276:immunology; D014614:Vaccines, Synthetic / Q000276:immunology
D000953:Antigens, Protozoan; D015815:Cell Adhesion Molecules; D017780:Malaria Vaccines; D015800:Protozoan Proteins; D019444:Vaccines, DNA; D022223:Vaccines, Subunit; D014614:Vaccines, Synthetic